Understanding the conformational impact of chemical modifications on monoclonal antibodies with diverse sequence variation using hydrogen/deuterium exchange mass spectrometry and structural modeling.

Chemical modifications can potentially induce conformational changes near the modification site and thereby impact the safety and efficacy of protein therapeutics. Hydrogen/deuterium exchange mass spectrometry (HDX-MS) has emerged as a powerful analytical technique with high spatial resolution and sensitivity in detecting such local conformational changes. In this study, we utilized HDX-MS combined with structural modeling to examine the conformational impact on monoclonal antibodies (mAbs) caused by common chemical modifications including methionine (Met) oxidation, aspartic acid (Asp) isomerization, and asparagine (Asn) deamidation. Four mAbs with diverse sequences and glycosylation states were selected. The data suggested that the impact of Met oxidation was highly dependent on its location and glycosylation state. For mAbs with normal glycosylation in the Fc region, oxidation of the two conserved Met252 and Met428 (Kabat numbering) disrupted the interface interactions between the CH2 and CH3 domains, thus leading to a significant decrease in CH2 domain thermal stability as well as a slight increase in aggregation propensity. In contrast, Met oxidation in the variable region and CH3 domain had no detectable impact on mAb conformation. For aglycosylated mAb, Met oxidation could cause a more global conformational change to the whole CH2 domain, coincident with the larger decrease in thermal stability and significant increase in aggregation rate. Unlike Met oxidation, Asn deamidation and Asp isomerization mostly had very limited effects on mAb conformation, with the exception of succiminide intermediate formation which induced a measurable local conformational change to be more solvent protected. Structural modeling suggested that the succinimide intermediate was stabilized by adjacent aromatic amino acids through ring-ring stacking interactions.

[1]  B. Yan,et al.  Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. , 2009, Journal of pharmaceutical sciences.

[2]  Ronald T Borchardt,et al.  Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. , 2006, Journal of pharmaceutical sciences.

[3]  B. Kabakoff,et al.  Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[4]  R. Bayer,et al.  The impact of glycosylation on monoclonal antibody conformation and stability , 2011, mAbs.

[5]  Damian Houde,et al.  Post-translational Modifications Differentially Affect IgG1 Conformation and Receptor Binding* , 2010, Molecular & Cellular Proteomics.

[6]  Alain Beck,et al.  Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. , 2009, Analytical biochemistry.

[7]  Paul Labute,et al.  Calibrative approaches to protein solubility modeling of a mutant series using physicochemical descriptors , 2010, J. Comput. Aided Mol. Des..

[8]  P. Labute,et al.  Antibody modeling assessment , 2011, Proteins.

[9]  W. Xu,et al.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies , 2012, mAbs.

[10]  Gang Huang,et al.  Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn , 2009, Protein science : a publication of the Protein Society.

[11]  Zhongqi Zhang,et al.  Improved protein hydrogen/deuterium exchange mass spectrometry platform with fully automated data processing. , 2012, Analytical chemistry.

[12]  Y. Yu,et al.  Using Hydrogen/Deuterium Exchange Mass Spectrometry to Study Conformational Changes in Granulocyte Colony Stimulating Factor upon PEGylation , 2012, Journal of The American Society for Mass Spectrometry.

[13]  S. Berkowitz,et al.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies. , 2011, Journal of pharmaceutical sciences.

[14]  L. Makowski,et al.  Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements. , 2013, Journal of pharmaceutical sciences.

[15]  Douglas S Rehder,et al.  Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. , 2005, Analytical chemistry.

[16]  Thomayant Prueksaritanont,et al.  Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. , 2009, Molecular immunology.

[17]  Jingming Zhang,et al.  Conformational characterization of the charge variants of a human IgG1 monoclonal antibody using H/D exchange mass spectrometry , 2013, mAbs.

[18]  L. Khawli,et al.  Charge variants in IgG1 , 2010, mAbs.

[19]  Paul Labute,et al.  LowModeMD - Implicit Low-Mode Velocity Filtering Applied to Conformational Search of Macrocycles and Protein Loops , 2010, J. Chem. Inf. Model..

[20]  D. Chelius,et al.  Accumulation of Succinimide in a Recombinant Monoclonal Antibody in Mildly Acidic Buffers Under Elevated Temperatures , 2007, Pharmaceutical Research.

[21]  Christian Bailly,et al.  Strategies and challenges for the next generation of therapeutic antibodies , 2010, Nature Reviews Immunology.

[22]  Da Ren,et al.  Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation. , 2008, Biochemistry.

[23]  Colleen E. Price,et al.  Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[24]  Huub Schellekens,et al.  Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice , 2011, Pharmaceutical Research.

[25]  J. M. Beals,et al.  In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. , 2005, Analytical chemistry.

[26]  Yang Wang,et al.  Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. , 2011, Molecular immunology.

[27]  Wei Wang,et al.  Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.

[28]  M. Mølhøj,et al.  Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures , 2012, PloS one.

[29]  Hongcheng Liu,et al.  Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  M. Shirts,et al.  Distinct Aggregation Mechanisms of Monoclonal Antibody Under Thermal and Freeze-Thaw Stresses Revealed by Hydrogen Exchange , 2011, Pharmaceutical Research.